Welcome to LookChem.com Sign In|Join Free
  • or
Trimethylsilyl leucinate is a chemical compound derived from leucine, an essential amino acid, and is commonly used as a protecting group for the carboxylic acid group of amino acids in organic synthesis. By attaching a trimethylsilyl group to the carboxylic acid group, the reactivity of the amino acid is reduced, enabling selective reactions to take place at other sites within the molecule. trimethylsilyl leucinate is particularly valuable in peptide synthesis, allowing chemists to selectively protect and deprotect the carboxylic acid group, which is essential for the creation of complex peptides and proteins. The trimethylsilyl group can be easily removed under mild conditions, making trimethylsilyl leucinate a versatile tool for synthetic chemists.

5269-60-3

Post Buying Request

5269-60-3 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

5269-60-3 Usage

Uses

Used in Organic Synthesis:
Trimethylsilyl leucinate is used as a protecting group for the carboxylic acid group of amino acids to decrease their reactivity, enabling selective reactions to occur at other sites within the molecule.
Used in Peptide Synthesis:
Trimethylsilyl leucinate is used as a selective protecting agent for the carboxylic acid group in the synthesis of complex peptides and proteins, allowing chemists to control the reactivity of the amino acid and facilitate the formation of desired peptide bonds.
Used in the Pharmaceutical Industry:
Trimethylsilyl leucinate is used as a synthetic intermediate in the development of pharmaceutical compounds, particularly in the synthesis of complex peptide-based drugs, where its ability to protect and deprotect the carboxylic acid group is crucial for achieving the desired molecular structures.

Check Digit Verification of cas no

The CAS Registry Mumber 5269-60-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,2,6 and 9 respectively; the second part has 2 digits, 6 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 5269-60:
(6*5)+(5*2)+(4*6)+(3*9)+(2*6)+(1*0)=103
103 % 10 = 3
So 5269-60-3 is a valid CAS Registry Number.

5269-60-3SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 18, 2017

Revision Date: Aug 18, 2017

1.Identification

1.1 GHS Product identifier

Product name O-(Trimethylsilyl)leucine

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:5269-60-3 SDS

5269-60-3Relevant academic research and scientific papers

De-novo designed library of benzoylureas as inhibitors of BCL-X L: Synthesis, structural and biochemical characterization

Brady, Ryan M.,Vom, Amelia,Roy, Michael J.,Toovey, Nathan,Smith, Brian J.,Moss, Rebecca M.,Hatzis, Effie,Huang, David C. S.,Parisot, John P.,Yang, Hong,Street, Ian P.,Colman, Peter M.,Czabotar, Peter E.,Baell, Jonathan B.,Lessene, Guillaume

, p. 1323 - 1343 (2014/03/21)

The prosurvival BCL-2 proteins are attractive yet challenging targets for medicinal chemists. Their involvement in the initiation and progression of many, if not all, tumors makes them prime targets for developing new anticancer therapies. We present our approach based on de novo structure-based drug design. Using known structural information from complexes engaging opposing members of the BCL-2 family of proteins, we designed peptidomimetic compounds using a benzoylurea scaffold to reproduce key interactions between these proteins. A library stemming from the initial de novo designed scaffold led to the discovery of ligands with low micromolar potency (KD = 4 μM) and selectivity for BCL-XL. These compounds bind in the canonical BH3 binding groove in a binding mode distinct from previously known BCL-2 inhibitors. The results of our study provide insight into the design of a new class of antagonists targeting a challenging class of protein-protein interactions.

Alpha-helical mimetics

-

Page/Page column 71, (2011/05/18)

Benzoyl urea derivatives that are alpha helical peptides mimetics that mimic BH3-only proteins, compositions containing them, their conjugation to cell-targeting-moieties, and their use in the regulation of cell death are disclosed. The benzoyl urea derivatives are capable of binding to and neutralizing pro-survival Bcl-2 proteins. Use of benzoyl urea derivatives in the treatment and/or prophylaxis of diseases or conditions associated with deregulation of cell death are also described.

ALPHA-HELICAL MIMETICS

-

Page/Page column 137-138, (2010/02/15)

Benzoyl urea derivatives that are alpha helical peptide mimetics that mimic BH3-only proteins, compositions containing them, their conjugation to cell-targeting moieties, and their use in the regulation of cell death are disclosed. The benzoyl urea derivatives are capable of binding to and neutralising pro-survival Bcl-2 proteins. Use of the benzoyl urea derivatives in the treatment and/or prophylaxis of diseases or conditions associated with deregulation of cell death are also disclosed.

Synthesis of lipidated eNOS peptides by combining enzymatic, noble metal- and acid-mediated protecting group techniques with solid phase peptide synthesis and fragment condensation in solution

Machauer, Rainer,Waldmann, Herbert

, p. 2940 - 2956 (2007/10/03)

Lipid-modified proteins play decisive roles in important biological processes such as signal transduction, organization of the cytoskeleton, and vesicular transport. Lipidated peptides embodying the characteristic partial structures of their parent lipida

SYNTHESIS OF THE AMIDE OF THE C-TERMINAL TETRAPEPTIDE OF THE SEQUENCE OF OXYTOCIN

Ivanov, A. K.,Antonov, A. A.,Donetskii, I. A.

, p. 344 - 349 (2007/10/02)

The synthesis has been effected of the amide of the tetrapeptide forming the sequence 6-9 of oxytocin with the use of benzyl protection of the thiol function of cysteine by two main schemes 1+3 and 2+2.The advantageousness of performing the synthesis by the 2+2 scheme has been shown.The overall yield of tetrapeptide using the method of condensation with the formation of mixed anhydrides amounted to 51percent by the scheme proposed.

Efficient "One-Pot" Synthesis of N-Trityl Amino Acids

Barlos, Kleomenis,Papaioannou, Dionysios,Theodoropoulos, Dimitrios

, p. 1324 - 1326 (2007/10/02)

A sequential procedure has been developed whereby neutral amino acids 1 were tritylated via their corresponding trimethylsilyl esters 2 to afford, after mild hydrolysis, N-trityl amino acids 3 in high yields and purity.Hydroxy amino acids 4 were preferent

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 5269-60-3